Thomas R. Malley's most recent trade in Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A was a trade of 78,233 Class A Ordinary Shares done at an average price of $33.1 . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Sale of securities on an exchange or to another person at price $ 33.09 per share. | 12 Aug 2025 | 78,233 | 12,546 (0%) | 0% | 33.1 | 2,588,730 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Sale of securities on an exchange or to another person at price $ 33.32 per share. | 12 Aug 2025 | 50,129 | 12,546 (0%) | 0% | 33.3 | 1,670,298 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 12 Aug 2025 | 49,407 | 12,546 (0%) | 0% | 32.4 | 1,600,787 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 33,237 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.33 per share. | 12 Aug 2025 | 33,237 | 64,543 (0%) | 0% | 14.3 | 476,286 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.88 per share. | 12 Aug 2025 | 30,000 | 62,675 (0%) | 0% | 9.9 | 296,400 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 30,000 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 12 Aug 2025 | 27,448 | 61,953 (0%) | 0% | 3.8 | 104,302 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 27,448 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.19 per share. | 12 Aug 2025 | 26,236 | 90,779 (0%) | 0% | 15.2 | 398,525 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 26,236 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 12 Aug 2025 | 21,959 | 34,505 (0%) | 0% | 1.9 | 40,844 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 21,959 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.36 per share. | 12 Aug 2025 | 20,129 | 32,675 (0%) | 0% | 10.4 | 208,536 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 20,129 | 0 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share. | 12 Aug 2025 | 18,760 | 31,306 (0%) | 0% | 15.5 | 290,217 | Class A Ordinary Shares |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 18,760 | 0 | - | - | Share Option | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 28,500 | 28,500 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 16,798 | 16,798 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 12,546 (0%) | 0% | - | Class A Ordinary Shares | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 2,799 | 2,799 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 19,040 | 19,040 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 9,373 (0%) | 0% | - | Class A Common Shares | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,173 | 3,173 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 5,000 (0%) | 0% | - | Class A Common Shares | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 0 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Purchase of securities on an exchange or from another person at price $ 11.50 per share. | 16 Jun 2023 | 50,000 | 139,557 (0%) | 0% | 11.5 | 575,000 | Common stock |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 26,236 | 26,236 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,373 | 4,373 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 30,000 | 30,000 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 33,237 | 33,237 | - | - | Share Option | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock |